Your location:Home page > Program
Search:
All Forums:
  • All
  • PDT School
  • Plenary Lecture & Invited Lecture
  • Photothermal Therapy
  • Chinese Clinical Application
  • Immunotherapy of Skin Cancers
  • New PDT Activation Sources
  • ROS and Explicit Dosimetry
  • Immunotherapy of Skin Diseases
  • PDT Dosimetry and Interstitial Delivery
  • Antimicrobial PDT/Infectious Diseases
  • Global health & Low-cost PDT
  • Brain
  • Urology
  • Rising Star Presentations
  • Dermatology & Gynecology
  • Gynecology
  • Gastroenterology and Hepatology
  • Head and neck diseases
  • Nanotechnology & Oncology
  • Novel photosensitizer and Nanotechnology
  • lmmunology
  • Respirology
  • Oral and Nasopharyngeal Diseases
  • Oncology
  • Dermatology
All Dates (UTC+8):
  • All
  • 2025-06-10 [Tuesday]
  • 2025-06-11 [Wednesday]
  • 2025-06-12 [Thursday]
  • 2025-06-13 [Friday]
  • 2025-06-14 [Saturday]
  • 2025-06-15 [Sunday]
All Rooms:
  • All
  • Auditorium 3F
  • Yellow River Hall, 3F
  • 3B
  • 3CD
  • 3HIJ
  • Front Lobby of the Auditorium
  • Pearl Hall 7F

2025-06-12 Thursday

3B (UTC+8)

10:15-12:15 (UTC+8) | Dermatology-2 [Dermatology]
NO. Beijing Time (UTC+8) Type Presentation Topic Speaker Affiliation / Organization
1 10:15-10:30 Oral Presentation

Comparative analysis of recurrence rates: day-light versus red-light photodynamic therapy in the treatment of actinic keratosis during a five-year follow-up

Yutong Yang Shanghai Skin Disease Hospital
2 10:30-10:45 Oral Presentation

A combination of subcutaneous sclerotherapy and hematoporphyrin monomethyl ether photodynamic therapy: An exploration of treatment for subcutaneous high-flow port-wine stains

Lidan Zhang West China Hospital, Sichuan University
3 10:45-11:00 Oral Presentation

The Impact of Different Treatment Intervals on the Efficacy of Hemoporfin-mediated Photodynamic Therapy for Pediatric Patients with Port-Wine Stain on the Peripheral Face

jingchen liang The Second Affiliated Hospital of Xi'an Jiaotong University
4 11:00-11:15 Oral Presentation

Observation of the Therapeutic Effectiveness of 5-Aminolevulinic Acid Photodynamic Maintenance Therapy in 30 Cases of Lichen Sclerosus Et Atrophicus(LSA)

Linuerhalifu Yi Department of Dermatology and Venereology,People’s Hospital of Xinjiang Uygur Autonomous Region
5 11:15-11:30 Oral Presentation

Photodynamic Therapy for Perifolliculitis capitis abscedens et suffodiens: A Case Series Demonstrating Long-Term Efficacy

Siqi Zheng Southern Medical University
6 11:30-11:45 Oral Presentation

Does the treatment interval of photodynamic therapy for facial port-wine stains affect the curative effect?

Sijin Li The First Affiliated Hospital of Kunming Medical University
7 11:45-12:00 Oral Presentation

Study on the effect and mechanism of Hemoporfin photodynamic inhibition on abnormal angiogenesis of port wine stain mediated by ATM-SerRS-VEGFA axis

Hong_yan Lu Department of Dermatology and Venereology, Nanfang Hospital, Southern Medical University
8 12:00-12:15 Oral Presentation

Hypericum perforatum-derived exosomes-like nanovesicles: A novel natural photosensitizer for effective tumor photodynamic therapy

Jianbo Wu Southwest Medical University
13:45-15:05 (UTC+8) | Gastroenterology and Hepatology-1 [Gastroenterology and Hepatology]
NO. Beijing Time (UTC+8) Type Presentation Topic Speaker Affiliation / Organization
1 13:45-14:05 Oral Presentation

Endovascular light-activated ablation to downstage locally advanced pancreatic cancers touching major blood vessels to assess feasibility for surgical excision

Stephen Bown UCL
2 14:05-14:25 Oral Presentation

Application of PDT in Intraductal Papillary Neoplasm of the Bile duct: preliminary experience

Jun Wu Eastern hepatobiliary surgery hospital
3 14:25-14:45 Oral Presentation

Photodynamic Therapy of Biliary Tract Tumors under Direct Visualization via Percutaneous Transhepatic towards the Hilar Bile Duct

Yanwen Jin Department of Biliary Surgery, West China Hospital, Sichuan University
4 14:45-15:05 Oral Presentation

Cosiporfin sodium (DVDMS)-mediated photodynamic therapy (PDT) versus treatment of physician’s choice (TPC) in patients (pts) with advanced esophageal cancer (aEC): a phase III, randomized, open-label, multicenter trial

Jun Zhou Peking University Cancer Hospital
15:45-16:30 (UTC+8) | Coffee Break